Ha seleccionado la visión en Inglés
Descriptor en español: |
Zanamivir
| ||||
Descriptor en inglés: | Zanamivir | ||||
Descriptor en portugués: | Zanamivir | ||||
Descriptor en francés: | Zanamivir | ||||
Término(s) alternativo(s): |
2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid 4 Guanidino Neu5Ac2en 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-Neu5Ac2en 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic GG 167 GG-167 GG167 Relenza |
||||
Código(s) jeráquico(s): |
D02.078.370.926 D02.241.081.844.562.668.775 D02.241.511.902.562.668.775 D03.383.663.859 D09.067.687.668.775 D09.811.589.668.775 |
||||
Identificador Único RDF: | https://id.nlm.nih.gov/mesh/D053243 | ||||
Nota de alcance: | A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE. |
||||
Calificadores permitidos: |
AA analogs & derivatives AD administration & dosage AE adverse effects AG agonists AI antagonists & inhibitors AN analysis BL blood CF cerebrospinal fluid CH chemistry CL classification CS chemical synthesis EC economics HI history IM immunology IP isolation & purification ME metabolism PD pharmacology PK pharmacokinetics PO poisoning RE radiation effects SD supply & distribution ST standards TO toxicity TU therapeutic use UR urine |
||||
Acción Farmacológica: |
Antivirales Inhibidores Enzimáticos |
||||
Número de registro: | L6O3XI777I | ||||
Nombre CAS Tipo 1: | 5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid | ||||
Nota Pública de MeSH: | 2007; ZANAMIVIR was indexed under SIALIC ACIDS (1998-2006) |
||||
Nota de historia: | 2007 |
||||
Identificador de DeCS: | 52164 | ||||
ID del Descriptor: | D053243 | ||||
Documentos indizados en la Biblioteca Virtual de Salud (BVS): | Haga clic aquí para acceder a los documentos de la BVS | ||||
Fecha de establecimiento: | 01/01/2007 | ||||
Fecha de entrada: | 05/07/2006 | ||||
Fecha de revisión: | 24/05/2017 |
-
-
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Organic Chemicals [D02]Organic Chemicals -
CHEMICALS AND DRUGS
Heterocyclic Compounds [D03]Heterocyclic Compounds -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates -
CHEMICALS AND DRUGS
Carbohydrates [D09]Carbohydrates
|
Zanamivir
- Concepto preferido
Relenza
- Más estrecho
GG 167
- Más estrecho
UI del concepto |
M0217195 |
Nota de alcance | A guanido-neuraminic acid that is used to inhibit NEURAMINIDASE. |
Término preferido | Zanamivir |
Término(s) alternativo(s) |
2,3-Didehydro-2,4-Dideoxy-4-Guanidino-N-Acetyl-D-Neuraminic Acid 2,3-Didehydro-2,4-Dideoxy-4-Guanidinyl-N-Acetylneuraminic Acid 4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid 4 Guanidino Neu5Ac2en 4-Guanidino-2,4-Dideoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic Acid 4-Guanidino-Neu5Ac2en 5-Acetylamino-2,6-Anhydro-4-Guanidino-3,4,5-Trideoxy-D-Galacto-Non-Enoic Acid Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic |
UI del concepto |
M0338009 |
Término preferido | Relenza |
UI del concepto |
M0217192 |
Término preferido | GG 167 |
Término(s) alternativo(s) |
GG-167 GG167 |
Queremos sus comentarios sobre el nuevo sitio web de DeCS / MeSH
Lo invitamos a completar una encuesta que no tomará más de 3 minutos.
Ir a la encuesta